CPIM
TXMD icon

Columbia Partners Investment Management’s TherapeuticsMD TXMD Stock Holding History

Columbia Partners Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,677
Closed -$869K – 370
2015
Q4 		$869K Buy
+1,677
New +$619K 0.06% 281

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Columbia Partners Investment Management's TXMD Position: Q1 2016 in Review

Columbia Partners Investment Management sold out of TherapeuticsMD (TXMD) in Q1 2016, closing a stake of 1,677 shares — an estimated $869K sold.

Columbia Partners Investment Management first reported a position in TXMD in Q4 2015 and held it in 1 quarter. The position peaked at $869K in Q4 2015. 128 funds tracked by Wall St. Rank hold TXMD as of Q1 2016.

  • Columbia Partners Investment Management reported no remaining TherapeuticsMD position as of Q1 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 1,677 TherapeuticsMD shares in Q1 2016, an estimated $869K.
  • Columbia Partners Investment Management first reported a position in TherapeuticsMD in Q4 2015 and held it in 1 quarter.
  • Columbia Partners Investment Management's TherapeuticsMD position peaked at $869K in Q4 2015.
  • 128 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2016.

Based on Columbia Partners Investment Management's 13F filing for Q1 2016, filed 10 May 2016.